TARGET M0035431540Recalls & reported problems
Stryker Corporation · Helical Nano Detachable Coil · Class 2 · Implant
All models of TARGET (114)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 04546540698056), received between Nov 2, 2016 and Aug 8, 2023 — classified as 2 injuries, 4 malfunctions.
The most frequently reported specific device problem is “Break” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Break2
- Premature Separation2
Patient problems
- No Consequences Or Impact To Patient3
- No Clinical Signs, Symptoms or Conditions2
- Thrombosis/Thrombus1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryAug 8, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING THE LEFT MIDDLE CEREBRAL ARTERY M2 ANEURYSM CASE WHILE DELIVERY OF THE SUBJECT COIL, RESISTANCE WAS ENCOUNTERED IN THE MICROCATHETER. ON WITHDRAWAL OF THE SUBJECT COIL, THROMBUS WAS GENERATED IN THE MICROCATHETER. THE THROMBUS WAS ASPIRATED FROM MICROCATHETER. THE PHYSICIAN REPLACED THE SUBJECT COIL WITH A NEW DEVICE AND CONTINUED THE PROCEDURE WITHOUT CLINICAL CONSEQUENCES TO THE PATIENT.
Patient problems: Thrombosis/Thrombus
MAUDE report 17480989 ↗InjuryJul 17, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A NEUROVASCULAR PROCEDURE, WHEN THE SUBJECT COIL WAS CLOSE TO THE DISTAL TIP OF THE MICROCATHETER, IT WAS EVIDENT THAT THE SUBJECT COIL BEGAN TO TWIST, TAKING ITS HELICAL SHAPE INSIDE THE MICROCATHETER. THE SUBJECT COIL GOT STUCK AND DID NOT ADVANCE TO THE ANEURYSM. THE OPERATOR RETRACTED THE SUBJECT COIL AND THEN ADVANCED IT AGAIN BUT THE SUBJECT COIL GOT STUCK AGAIN AND DID NOT ADVANCE. THEREFORE HE DECIDED TO REMOVE THE SUBJECT COIL. A UNKNOWN MEDICAL INTERVENTION WAS REPORTED DUE TO THIS EVENT. SURGICAL DELAY OF 5 MINUETS WAS NOTED. IN ADDITION THE FILLING OF THE ANEURYSM COULD NOT BE FINISHED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17339643 ↗MalfunctionJun 25, 2021Premature Separation; Premature Separation
THE DEVICE WAS RETURNED FOR ANALYSIS AND THE INVESTIGATION OF THE DEVICE REVEALED THAT THE COIL (SUBJECT DEVICE) DETACHED FROM THE DELIVERY WIRE DURING THE PROCEDURE. NO CLINICAL CONSEQUENCES WERE REPORTED TO THE PATIENT DUE TO THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12068468 ↗MalfunctionApr 8, 2020Premature Separation; Premature Separation
IT WAS REPORTED THAT DURING THE PROCEDURE THE SUBJECT COIL WAS NOTED TO BE STRETCHED AND HAD PREMATURELY DETACHED DURING USE. THE PHYSICIAN REPLACED WITH ANOTHER OF THE SAME DEVICE AND COMPLETED THE PROCEDURE SUCCESSFULLY. THE PATIENT WAS STABLE AND NO CLINICAL CONSEQUENCES WERE REPORTED TO THE PATIENT DUE TO THIS EVENT. ANALYSIS OF THE RETURNED DEVICE REVEALED THAT THE SUBJECT COIL WAS NOT PREMATURELY DETACHED AS THE COIL WAS STILL INTACT THEREFORE, BASED ON THIS INFORMATION THE EVENT IS DEEMED NON-REPORTABLE AND EMDR REDACTION WILL BE FILED WITH AN AWARE DATE OF 27-JUL-2020. THE EVENT WILL BE RE-ASSESSED TO REFLECT THE DECISION CHANGE AND EMDR WILL BE FILED ACCORDINGLY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9936343 ↗MalfunctionNov 2, 2016Break; Break
IT WAS REPORTED THAT AFTER THE COIL WAS INTRODUCED INTO THE ANEURYSM, THE PHYSICIAN DECIDED TO RESHEATH THE COIL TO BE RE-INTRODUCED INTO THE MICROCATHETER. THE COIL BROKE OFF AT THE JUNCTION OF THE MICROCATHETER DURING RE-INTRODUCTION. THE PHYSICIAN CUT THE HUB OF THE MICROCATHETER TO RETRIEVE THE BROKEN COIL. THERE WERE NO REPORTED CLINICAL CONSEQUENCES TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6074671 ↗MalfunctionNov 2, 2016Break; Break
IT WAS REPORTED THAT AFTER THE COIL WAS INTRODUCED INTO THE ANEURYSM, THE PHYSICIAN DECIDED TO RESHEATH THE COIL TO BE RE-INTRODUCED INTO THE MICROCATHETER. THE COIL BROKE OFF AT THE JUNCTION OF THE MICROCATHETER DURING RE-INTRODUCTION. THE PHYSICIAN CUT THE HUB OF THE MICROCATHETER TO RETRIEVE THE BROKEN COIL. THERE WERE NO REPORTED CLINICAL CONSEQUENCES TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6074651 ↗
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page